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Introduction {#sec1}
============

In neurons, mitochondrial fission, which in mammals depends mainly on dynamin-related protein Drp1, facilitates both axonal mitochondrial transport and mitophagic elimination ([@bib35], [@bib36], [@bib46], [@bib49]). Not surprisingly, Drp1 is therefore required for brain development and mature neuronal function ([@bib3], [@bib21], [@bib22], [@bib35], [@bib40], [@bib50]). In several clinically and pathologically distinct neurodegenerative diseases, mitochondrial morphology is disrupted (reviewed by [@bib14]), substantiating the link among mitochondrial dynamics, function, and brain pathophysiology. Given this, brain mitochondrial dysfunction could represent an important marker to identify subjects at risk of developing neurodegenerative disorders, before neurological symptoms manifest; however, no surrogate marker of brain mitochondrial dysfunction is available.

Mitochondria of peripheral organs (e.g., liver and muscle) can convey disruption of their function by mounting cell-wide stress responses ([@bib8], [@bib17], [@bib18], [@bib23], [@bib27], [@bib45], [@bib47]). A common trait of these models is the expression, causally linked to mitochondrial dysfunction, of the metabolic cytokine fibroblast growth factor 21 (Fgf21). This cytokine exerts a plethora of tissue-specific effects and is subject to complex pharmacology and pharmacokinetics, aspects of which continue to be matter of debate (reviewed by [@bib25]). In addition to being canonically produced by liver and white adipose tissue (WAT) in response to starvation, Fgf21 can be secreted by other organs, such as pancreas and brown adipose tissue ([@bib11], [@bib15]). Moreover, Fgf21 has been established as a marker of mitochondrial myopathies ([@bib43], [@bib44]). Whether Fgf21 is also produced by the CNS in response to mitochondrial dysfunction is unknown. Here we capitalize on our previously generated mouse model of inducible mitochondrial fission ablation in mature forebrain neurons ([@bib35]), as well as on bona fide mouse models of neurodegeneration, to demonstrate that various forms of neuronal cell stress, including mitochondrial dysfunction, are sensed by the integrated stress response (ISR). In each of these models, ISR activation leads to neuron-specific Fgf21 expression, highlighting the potential of this cytokine as biomarker for neurodegenerative conditions.

Results {#sec2}
=======

Neuronal *Drp1* Ablation Activates the ISR, Resulting in Fgf21 Induction {#sec2.1}
------------------------------------------------------------------------

We previously generated a model of inducible ablation of the mitochondrial fission protein Drp1 in the adult mouse forebrain (*Drp1*^*flx/flx*^; *CaMKIIα::CreERT2*, tamoxifen-inducible *Drp1* deletion from brain, *Drp1*^*i*Δb/iΔb^). In this model, neuronal *Drp1* ablation compromised mitochondrial respiration and shifted cellular metabolism toward glycolysis ([@bib35]); in addition, systemic catabolic changes occurred, which prompted further investigation.

Because mitochondrial dysfunction in several peripheral organs can lead to the induction of the cytokine Fgf21 ([@bib24], [@bib27], [@bib43]), we checked whether the same was true for a brain-specific mitochondrial defect. Starting 7 weeks post-tamoxifen injection (PTI, i.e., after *Drp1* ablation), we found elevated Fgf21 plasma levels ([Figure 1](#fig1){ref-type="fig"}A), prompting us to investigate its source organ or organs. Subsequent analyses revealed that as early as 4 weeks after *Drp1* ablation, *Fgf21* transcription was induced specifically in hippocampus and cortex but not in: the cerebellum (where the *Cre*-driving *CaMKIIα* promoter is inactive); the canonical Fgf21 sources (liver and adipose tissue); or the skeletal muscle ([Figure 1](#fig1){ref-type="fig"}B). These results establish brain as the Fgf21 tissue source in our model. mRNA fluorescence *in situ* hybridization identified neurons as the primary Fgf21 producers in the *Drp1*-ablated mouse brain, shown in [Figures 1](#fig1){ref-type="fig"}C and 1D for the hippocampal CA1 region ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C detail the histological distribution of hippocampal pyramidal neurons for reference; for comparison, [Figures S1](#mmc1){ref-type="supplementary-material"}D and S1E show the distribution of astrocytes and microglia). These observations are significant from two perspectives: we demonstrate that Fgf21 can be produced by neurons in response to mitochondrial dysfunction ([@bib4], [@bib43], [@bib16]) and that Fgf21 produced in the brain can cross the blood-brain barrier (BBB) to become detectable in plasma ([@bib24]).Figure 1Neuronal *Drp1* Ablation Induces ISR-Driven Brain Fgf21 Expression(A) FGF21 plasma levels in cardiac blood of *Drp1*-ablated and control mice. Positive control represents overnight-starved animals. Data represent average + SEM of at least 3 animals.(B) qRT-PCR analysis of different mouse tissues at indicated time points PTI. *Fgf21* mRNA ct values normalized against 18S rRNA ct values. Data represent average + SEM of at least 4 animals.(C and D) Representative *Fgf21* mRNA-fluorescence *in situ* hybridization (FISH) analysis of the hippocampal CA1 region of a *Drp1*-ablated mouse at 10 weeks PTI (C). Fgf21 mRNA hybridization signals are in green; nuclei are DAPI stained. Scale bar, 20 μm. Quantification of hybridization signals (D).(E) Representative western blots of *Drp1*-ablated and control hippocampal lysates separated by SDS-PAGE and immunoblotted using indicated antibodies.(F and G) Quantification of phosphorylated elF2α band intensity normalized to total elF2α (F) and Atf4 intensity normalized to actin (G). Data represent average + SEM of at least 4 animals.(H) qRT-PCR analysis of *Chop* expression in various mouse brain regions. Data represent average + SEM of at least 4 animals.

The ISR Is Activated upon Neuronal *Drp1* Ablation {#sec2.2}
--------------------------------------------------

We next wished to understand how mitochondrial dysfunction led to neuronal *Fgf21* transcription. Among the transcription factors known to control *Fgf21* expression, only *Atf4* was upregulated in *Drp1*-ablated brains ([Figure S2](#mmc1){ref-type="supplementary-material"}A). *Atf4* translation is activated by phosphorylated eukaryotic translation initiation factor 2α (eIF2α), a crucial node in the ISR, responding to different forms of stress via decreased global translation and activation of transcriptional programs aimed at damage control ([@bib12]). Western blot analysis confirmed Atf4 increase and eIF2α phosphorylation in *Drp1*^*iΔb/iΔb*^ hippocampi ([Figures 1](#fig1){ref-type="fig"}E--1G). The canonical Atf4 target gene *Chop* (*Ddit3* or *Gadd153*) was accordingly upregulated in *Drp1*^*iΔb/iΔb*^ hippocampus and cortex ([Figure 1](#fig1){ref-type="fig"}H). Furthermore, proteomics revealed that Atf4 target genes were significantly enriched in *Drp1*^*iΔb/iΔb*^ brains ([Figure S2](#mmc1){ref-type="supplementary-material"}B).

Four eIF2α kinases are capable of sensing specific ISR-triggering stress conditions: Perk responds to endoplasmic reticulum (ER) stress; Gcn2 acts as sensor for amino acid deficiency activated by uncharged tRNAs; Pkr senses double-stranded RNAs to signal viral infections and transduces the mitochondrial unfolded protein response (mtUPR) ([@bib39]); and HRI becomes activated in the absence of heme ([@bib12]). *In vivo*, the eIF2α-phosphorylating arm or arms of the ISR could not be detected by direct immunoblot (due to paucity of their expression and the mixed cellular nature of brain lysates). However, we investigated the specific upstream stress or stresses triggering the Fgf21-inducing cascade as a proxy for their respective ISR arm activation.

The close apposition of ER and mitochondria favors ER stress upon loss of proteins involved in mitochondrial and ER morphology regulation ([@bib9], [@bib34]). Drp1 was originally identified as a modulator of mitochondrial, as well as ER shape ([@bib37], [@bib53]), suggesting that its deletion might also affect the ER. Electron microscopy (EM) of hippocampi 4 weeks PTI revealed that the ER was round and swollen, unlike the flat ER cisternae in the *Drp1*^*flx/flx*^ counterparts ([Figure 2](#fig2){ref-type="fig"}A). In addition, the ER stress marker Bip/GRP78 was upregulated in *Drp1*^*iΔb/iΔb*^ brains at later stages ([Figures 2](#fig2){ref-type="fig"}B and 2C), pointing to a link between neuronal *Drp1* deletion and ER stress activation. As a proof of principle, when we intraventricularly injected wild-type mice with the ER stress inducer tunicamycin, we noticed not only an activated unfolded protein response (UPR), as reflected by eIF2α phosphorylation and Atf4 elevation, but also an increase in *Fgf21* mRNA ([Figures 2](#fig2){ref-type="fig"}D--2F), leading to an elevation in plasma Fgf21 levels ([Figure 2](#fig2){ref-type="fig"}G). Altogether, these data indicate that *Drp1*^*iΔb/iΔb*^ brains mount an UPR and that brain ER stress is sufficient to induce local Fgf21 expression and plasma Fgf21 elevation.Figure 2ER Stress Is Present and Sufficient for Fgf21 Induction upon *Drp1* Ablation(A) Representative transmission electron microscopy (TEM) images of ER (marked by black arrows) of hippocampal neurons of 4-week-*Drp1*-ablated and control mice. Scale bar, 1 μm.(B) Bip and actin western blot on hippocampal lysates of mice of the indicated genotypes at 10 weeks PTI. This experiment shares a loading control with [Figure 1](#fig1){ref-type="fig"}E.(C) Quantification of Bip band intensity normalized to actin. Data represent average + SEM of at least 4 animals.(D--G) Markers of ER stress and Fgf21 levels in brain tissue and plasma following intraventricular tunicamycin (TUM) injection.(D) Fgf21 mRNA in TUM- and Sham-injected hippocampi.(E and F) Representative western blot (E) and quantification (F) of TUM- and Sham-injected hippocampal lysates probed for the indicated proteins. Data represent average + SEM of at least 3 animals.(G) Fgf21 plasma levels as determined by ELISA. Data represent average + SEM of at least 5 animals.

The ER Stress Component Is Dispensable for Fgf21 Induction {#sec2.3}
----------------------------------------------------------

To understand whether ER stress was necessary to induce *Fgf21* expression, we capitalized on the orally bioavailable chemical chaperone tauroursodeoxycholic acid (TUDCA), which reduces mitochondria-induced ER stress in flies and mice ([@bib10], [@bib34]). Co-treatment of *Drp1*^*i*Δb/iΔb^ mice with TUDCA and tamoxifen resulted in lower Bip and P-eIF2α levels, confirming TUDCA bioavailability and activity in the brain. However, eIF2α phosphorylation and expression of *Fgf21*, as well as of the canonical Atf4 target gene *Chop*, remained elevated in TUDCA-treated *Drp1*^*iΔb/iΔb*^ mice ([Figures 3](#fig3){ref-type="fig"}A--3E).Figure 3ER Stress-Independent ISR Branches Contribute to Fgf21 Induction(A--E) Analysis of TUDCA-treated *Drp1*-ablated and control mice.(A) Representative western blots of hippocampal lysates of the indicated genotype 10 weeks PTI, probed for Bip, P-eIF2α, total eIF2α, Atf4, and actin.(B and C) Quantification of Bip (B) and phosphorylated elF2α (C) band intensities normalized to actin (Bip) or total eIF2α, respectively.(D and E) Hippocampal *Fgf21* (D) and *Chop* (E) mRNA expression determined by qRT-PCR, normalized to 18S rRNA ct values. Data represent average + SEM of at least 4 animals.(F) Free amino acids in the indicated brain regions 10 weeks PTI. Data represent average ± SEM of at least 4 animals.(G) Fold change in selected hits of a total proteomics screen 10 weeks PTI, plotted as a function of the respective q value.(H) Fold change in selected, iron-related hits of a proteomics screen 10 weeks PTI.Asterisks in (E) denote q values (i.e., p values adjusted for multiple testing): ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

Overall, although ER stress is present in *Drp1*^*iΔb/iΔb*^ brains and can cause *Fgf21* expression, its inhibition alone is not sufficient to abolish *Fgf21* in our model, suggesting that one or more of the alternative ISR branches contribute to the observed phenotype.

Impaired Amino Acid and Iron Metabolism Contributes to ISR-Driven Fgf21 Induction {#sec2.4}
---------------------------------------------------------------------------------

To understand which mechanism accounted for Fgf21 production, we explored the role of the mitochondrial bioenergetics defect caused by *Drp1* ablation ([@bib35]). However, at 10 weeks PTI, protein levels of Hsp60 and mRNA levels of *Hsp10*, *ClpP*, and *Yme1l*, markers of the mtUPR, were normal in *Drp1*^*iΔb/iΔb*^ brains ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). We confirmed this by an unbiased proteomic analysis on pooled hippocampi and cortices from mice 10 weeks PTI: mtUPR was not in place in *Drp1*^*iΔb/iΔb*^ mice, with three of the five acknowledged mtUPR genes even significantly decreased ([Figure S3](#mmc1){ref-type="supplementary-material"}D).

Alternatively, ISR could result from a defect in amino acid biosynthesis or catabolism, both crucially located at the mitochondrial level. Total amino acid content was moderately decreased in the hippocampus, whereas amino acids were significantly increased in the cortex of *Drp1*^*iΔb/iΔb*^ mice ([Figure 3](#fig3){ref-type="fig"}F). In addition, aminoacyl-tRNA synthetases were significantly enriched hits of the proteomics analysis of *Drp1*^*iΔb/iΔb*^ brains. Even more remarkable was the signature of the subcellular distribution of the altered aminoacyl-tRNA synthetases: 80% of cytosolic aminoacyl-tRNA synthetases were significantly upregulated in *Drp1*^*iΔb/iΔb*^ brains, while their mitochondrial counterparts were mostly downregulated ([Figure 3](#fig3){ref-type="fig"}G). Because heme biosynthesis depends on amino acid metabolism, as well as on mitochondrial function ([@bib29]), we next wanted to check its potential involvement in the phenotype. Ferrochelatase, a rate-limiting mitochondria-localized component of the heme biosynthetic pathway, was downregulated in *Drp1*^*iΔb/iΔb*^ mice, as was mitochondrial matrix iron metabolism regulator frataxin ([Figure 3](#fig3){ref-type="fig"}H). Accordingly, cytosolic iron storage protein ferritin H was upregulated, and iron importer transferrin receptor was downregulated in *Drp1*^*iΔb/iΔb*^ brains. Finally, heme-containing hemoglobin was also strongly downregulated in *Drp1*^*iΔb/iΔb*^ brains ([Figure 3](#fig3){ref-type="fig"}H), reflecting the global changes in iron metabolism caused by Drp1 ablation. Altogether, these data suggest that both amino acid metabolism and heme biosynthesis are altered upon *Drp1* ablation and may contribute to ISR activation in *Drp1*^*iΔb/iΔb*^ mice.

Brain-Derived Fgf21 Is Induced in Two Etiologically Distinct Mouse Models of Neurodegeneration {#sec2.5}
----------------------------------------------------------------------------------------------

We next wished to investigate the possibility that Fgf21 was induced in clinically relevant models of brain pathologies affecting mitochondrial dynamics and function. To this end, we examined tau-mutated P301L mice, a model of frontotemporal dementia (FTD) ([@bib30]), as well as the tg37-Rocky Mountain Laboratory (RML) prion inoculation model ([@bib31], [@bib32]). Both models display ISR that responds to PERK inhibition ([@bib32], [@bib38]), as well as defects in mitochondrial function and transport ([@bib6], [@bib7]). In both models, the ER stress and ISR activation markers Bip, P-eIF2α, and Atf4 were upregulated ([Figures 4](#fig4){ref-type="fig"}A--4C, 4E, and 4F). *Fgf21* mRNA was elevated in hippocampi of P301L, as well as of prion-injected mice at different time points, also before the onset of symptoms ([Figures 4](#fig4){ref-type="fig"}D and 4H). Prion-inoculated mice orally treated with PERK inhibitor GSK2606414 showed a demonstrable decrease in Fgf21 expression, confirming that Fgf21 induction is ER stress dependent ([Figure 4](#fig4){ref-type="fig"}H). Thus, *Fgf21* transcription is induced in etiologically distinct mouse models of neurodegeneration not caused by a primary mitochondrial defect. Our data collectively indicate that Fgf21 might be an early biomarker for neurodegenerative processes associated with mitochondrial dysfunction and ISR activation.Figure 4Brain-Derived Fgf21 Is Induced in Mouse Models of NeurodegenerationData from P301L tau mutant mice (A--D) and RML prion inoculation disease model (E--H).(A) Western blot of hippocampi of 9-month-old P301L mutant mice and age-matched controls.(B and C) Quantification of Bip (B) and Atf4 (C) band intensities, normalized to their respective loading control.(D) Hippocampal *Fgf21* mRNA expression of 9-month-old P301L mutant mice and age-matched controls, determined by qRT-PCR. Data represent average + SEM of at least 4 animals.(E) Western blot of hippocampi of mice intracerebrally inoculated with RML prions at 10 weeks postinoculation (wpi).(F and G) Quantification of Bip (F) and Atf4 (G) band intensities normalized to their respective loading control.(H) Fgf21 transcript levels in hippocampi of normal brain homogenate (NBH) or RML prion-inoculated mice at 6, 8, and 10 wpi. Data represent average + SEM of at least 8 animals.

Discussion {#sec3}
==========

Here, we report that *Drp1* deletion from adult forebrain neurons *in vivo* triggers the activation of a multi-branched stress response culminating in brain *Fgf21* expression. Impaired mitochondrial function is linked to Fgf21 production in various peripheral tissues, but not in brain ([@bib8], [@bib17], [@bib18], [@bib23], [@bib27], [@bib28], [@bib45], [@bib47]). In our system, *Drp1* deletion impairs mitochondrial dynamics and ER morphology and induces ER stress ([Figure 2](#fig2){ref-type="fig"}). This could be due to alterations in mitochondria-ER contacts affecting the two organellar membranes, modifying membrane curvature and activating ER stress sensor PERK ([@bib48]), or due to direct Drp1 action on ER shape ([@bib53]). Lack of rescue by TUDCA treatment ([Figures 3](#fig3){ref-type="fig"}A--3E) indicates that additional stress pathways converging on eIF2α are activated in the brain upon Drp1 deletion. In particular, heme biosynthesis and amino acid metabolism, two mitochondria-related pathways, are affected by brain *Drp1* ablation ([Figures 3](#fig3){ref-type="fig"}F--3H). Heme biosynthesis is a partially mitochondria-resident pathway that requires iron to be actively imported into the organelles, as well as amino acids as precursors. Therefore, given the compromised bioenergetic state of Drp1-ablated mitochondria, which could affect organellar iron import, it is plausible that intramitochondrial steps of heme biosynthesis are impaired. This is corroborated by the increase in cytosolic ferritin H and the decrease in transferrin receptor (a signature of high cytosolic iron) ([@bib33]). The stark decrease of two hemoglobin subunits, which would bind heme, is also in line with the heme deprivation hypothesis ([Figure 3](#fig3){ref-type="fig"}H) ([@bib5], [@bib19]).

Different brain regions display differential sensitivity to *Drp1* deletion, reflecting their individual metabolic needs and responses ([@bib3], [@bib22], [@bib35], [@bib40]). One explanation can lie in the ability of Atf4 to act with other transcription factors in a combinatorial manner based on the nature of the stress ([@bib26]). Total amino acid concentration varied drastically between hippocampus and cortex ([Figure 3](#fig3){ref-type="fig"}F), which could be linked to the presence, in the anterior piriform cortex, of the body's amino acid deficiency sensor ([@bib1]). It is therefore conceivable that the differential sensitivity to Drp1 ablation is linked to the different degrees of amino acid concentration changes within the brain.

The importance of Fgf21 as a proxy of brain mitochondrial defects is reinforced by the finding that *Fgf21* is expressed in brains of prion-inoculated mice, as well as of mice carrying the FTD-associated P301L tau mutation ([Figures 4](#fig4){ref-type="fig"}D and 4H). Similar to *Drp1*-deleted mice, both models display defects in mitochondrial function and transport, as well as ER stress-dependent ISR activation that can be reversed by PERK blockage ([@bib7], [@bib38]). Although dysregulated iron and heme have also been linked to tau accumulation and prion diseases ([@bib2], [@bib41]), ISR activation in these models is exclusively PERK dependent, which makes them an ideal model to study the reversal of Fgf21 expression by GSK2606414.

Fgf21 is regulated by circadian and nutritional factors ([@bib15], [@bib25]), potentially limiting the specificity of its detection *in vivo* as a biomarker of neuronal mitochondrial dysfunction. In particular, liver Fgf21 production is modulated by diverse dietary manipulations beyond fasting ([@bib15]). For these reasons, the exploration of Fgf21 levels in patients\' samples was beyond the scope of this work. Nevertheless, in light of our findings and of Fgf21 being a biomarker of mitochondrial myopathies, we encourage clinicians to explore this possibility in existing, appropriately controlled patient cohorts. Of course, confounding factors such as diabetes, obesity, or liver disease shall be carefully considered. To this end, cerebrospinal fluid (CSF) analyses might prove relevant, although at least upon its acute peripheral injection in mice, this cytokine can also cross the BBB ([@bib13], [@bib20]).

Future work grounded in the discoveries reported here will test whether Fgf21 is induced in other diseases sharing mitochondrial and ER stress components, like Parkinson's disease and disorders of the amyotrophic lateral sclerosis/FTD spectrum ([@bib42], [@bib51], [@bib52]). While we do not expect Fgf21 to aid in the diagnostic discrimination of different neurodegenerative entities, we can predict that our discovery of a secreted, brain-derived factor induced in etiologically diverse CNS diseases would represent a much-needed progress in presymptomatic screening, within a combined framework of validated biomarkers and predictive algorithms.

In conclusion, our work shows that neurons sense dysregulated mitochondrial dynamics and ER stress to activate a multi-branched stress response culminating in the release of Fgf21. The same Fgf21 mitokine is produced in the brains of bona fide tauopathy and prion disease mouse models, highlighting its potential as a marker of brain mitochondrial dysfunction.

Experimental Procedures {#sec4}
=======================

For more details, refer to the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Mice {#sec4.1}
----

*Drp1*^*i*Δb/iΔb^ and tau mutant (P301L) mice were described previously ([@bib35], [@bib30], [@bib38]). For the prion disease model, hemizygous tg37 mice inoculated with RML prion were used ([@bib31], [@bib32]).

Western Blot {#sec4.2}
------------

Lysates of perfused mouse brains were analyzed as previously described ([@bib35]). Antibodies are listed in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Real-Time PCR {#sec4.3}
-------------

Organs were collected from PBS-perfused mice and RNA was isolated (RNeasy kits 74104, 74704, and 74804). RT-PCR was performed using the High Capacity cDNA Reverse Transcription Kit (Invitrogen, 4368814). Real-time PCR was performed using TaqMan assays (Life Technologies) on a 7900HT Real-Time PCR System (Applied Biosystems). TaqMan assays are listed in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Cross-threshold (ct) values were normalized to 18S ct values.

Fluorescent Detection of *Fgf21* mRNA {#sec4.4}
-------------------------------------

This analysis was performed as a service by Advanced Cell Diagnostics with the RNAscope technology, following the standard manufacturer's protocol.

ELISA {#sec4.5}
-----

Blood was collected between 9 and 10 a.m., and plasma Fgf21 levels were analyzed according to the manufacturer's instructions (BioVendor, RD291108200R).

Quantitative Proteomics {#sec4.6}
-----------------------

Details on this analysis were described previously ([@bib35]). Data are available via ProteomeXchange: [PXD004890](pride:PXD004890){#intref0010}.

Statistics {#sec4.7}
----------

Data analysis was performed with GraphPad Prism 6. For statistical analyses, two-tailed Student's t test and one-way ANOVA with Sidak's multiple comparison corrections were used. Unless otherwise specified, asterisks denote p values of an unpaired, two-tailed Student's t test: ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001.
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